Quantcast

Latest Bite Stories

2d2cecc58643b45906af9e4acfe229251
2009-09-28 12:05:55

The Chinese government reported that China is second only to India in the number of people worldwide who are killed by rabies every year, making the disease one of the nation's biggest public health threats, AFP reported. A statement released by the health ministry said China is one of the countries most severely affected by rabies, and in recent years the number of annual reported deaths from rabies has averaged around 2,400. "It is only inferior in number to India, and gives us the world's...

2009-09-22 06:00:00

BETHESDA, Md., Sept. 22 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the appointment of Jan Fagerberg, M.D., Ph.D., as Senior Vice President and Chief Medical Officer effective November 1, 2009. Dr. Fagerberg is a board-certified clinical oncologist and has more than 20 years of experience in clinical research and development...

2009-09-21 08:14:00

BETHESDA, Md., Sept. 21 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today presented first interim data from a phase 1 dose-escalation clinical study for BiTE antibody MT110, the first T-cell engaging antibody for the treatment of solid tumors. The interim data(1) were presented at the Multidisciplinary Congress of the European Cancer...

2009-09-17 14:02:00

BETHESDA, Md., Sept. 17 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it will host a conference call and webcast on September 22, 2009 at 7:00 am U.S. Eastern Time to discuss the data from a phase 1 clinical trial with Micromet's anti-EpCAM BiTE antibody MT110, which was presented on September 21, 2009 at the joint 15th...

2009-09-16 11:00:00

BETHESDA, Md., Sept. 16 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that its President and CEO, Dr. Christian Itin, will present at the UBS Global Life Sciences Conference on September 22, 2009 in New York City. A simultaneous webcast of the event will be available on the company's website at www.micromet-inc.com....

2009-09-15 10:00:00

BETHESDA, Md., Sept. 15 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that its President and CEO, Dr. Christian Itin, will present at the 16th Annual NewsMakers in the Biotech Industry Conference on September 16, 2009 in New York City. A simultaneous webcast of the event will be available on the company's website at...

2009-09-01 12:54:28

There may be a way around the harsh skin toxicity associated with a widely used cancer drug, according to a study published online this week in Cancer Biology and Therapy by researchers from City of Hope and the Kimmel Cancer at Jefferson.Cetuximab (Erbitux) is a monoclonal antibody that binds to and inhibits the epidermal growth factor receptor (EGFR). It is widely used to treat colorectal cancer and head and neck cancer. Although cetuximab and other EGFR inhibitors are associated with a...

2009-08-17 00:51:56

Children ages 5-9 -- especially boys -- are at greatest risk of dog bites, a U.S. veterinarian says. Dr. Kate Stenske of the University of Kansas says small boys are probably at most risk due to their size and proximity to dogs, their loud noises, fast movements, unintentional provoking and lack of understanding of dogs' body language. Usually, the boys' injuries are usually the most serious from pet bites, Stenske says. Wounds that are most likely to become infected are those on the face and...

2009-08-10 11:17:08

The sex hormone estrogen plays a critical role in the regulation of growth and the development of cells. It is also crucial for cell-type-specific gene expression in various tissues. Deregulation of this system results in breast and ovarian cancer. Those tumors are successfully treated with drugs such as tamoxifen. Researchers suggest that this drug inhibits tumor growth by blocking the estrogen receptors of the tumor cells. However, up to now it has been unclear what effect this...

2009-08-06 06:00:00

BETHESDA, Md., Aug. 6 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced its financial results for the second quarter and six months ended June 30, 2009. In the second quarter of 2009, Micromet achieved a number of significant milestones illustrating its continued progress in the clinic and in corporate development. The milestones...


Latest Bite Reference Libraries

0_e288c9a7e7e932afbeba3516c20e64f2
2009-06-16 22:38:30

The Brown Recluse Spider (Loxosceles reclusa) is a species of arachnid that is native to the USA from the southern Midwest south to the Gulf of Mexico. It can be found in Canada as well around southeast Ontario, and southern Quebec. Its range lies from southeastern Nebraska through southern Iowa, Illinois, and Indiana to southwestern Ohio. In the south, it is native from central Texas to western Georgia. It is not usually found west of the Rocky Mountains. Contrary to popular belief, this...

More Articles (1 articles) »
Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related